A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...

The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

The kappa opioid receptor (KOR) and the endogenous peptide-ligand dynorphin ... in modulating dopaminergic neurotransmission in reward circuitry and the influence of dopamine in the transduction and ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids’ addictive effects.